These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8695816)
1. Fluorescence in situ hybridization analysis of t(3; 12)(q26; p13): a recurring chromosomal abnormality involving the TEL gene (ETV6) in myelodysplastic syndromes. Raynaud SD; Baens M; Grosgeorge J; Rodgers K; Reid CD; Dainton M; Dyer M; Fuzibet JG; Gratecos N; Taillan B; Ayraud N; Marynen P Blood; 1996 Jul; 88(2):682-9. PubMed ID: 8695816 [TBL] [Abstract][Full Text] [Related]
2. Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13). Nakamura Y; Nakazato H; Sato Y; Furusawa S; Mitani K Am J Hematol; 2002 Jan; 69(1):80-2. PubMed ID: 11835339 [TBL] [Abstract][Full Text] [Related]
3. Fusion of ETV6 to MDS1/EVI1 as a result of t(3;12)(q26;p13) in myeloproliferative disorders. Peeters P; Wlodarska I; Baens M; Criel A; Selleslag D; Hagemeijer A; Van den Berghe H; Marynen P Cancer Res; 1997 Feb; 57(4):564-9. PubMed ID: 9044825 [TBL] [Abstract][Full Text] [Related]
4. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Wlodarska I; Mecucci C; Marynen P; Guo C; Franckx D; La Starza R; Aventin A; Bosly A; Martelli MF; Cassiman JJ Blood; 1995 May; 85(10):2848-52. PubMed ID: 7742547 [TBL] [Abstract][Full Text] [Related]
5. A novel variant of acute myelomonocytic leukemia carrying t(3;12)(q26;p13) with characteristics of 3q21q26 syndrome. Iwase S; Furukawa Y; Horiguchi-Yamada J; Nemoto T; Takahara S; Kawano T; Sekikawa T; Ito K; Yamazaki Y; Kikuchi J; Morishita K; Yamada H Int J Hematol; 1998 Jun; 67(4):361-8. PubMed ID: 9695409 [TBL] [Abstract][Full Text] [Related]
6. [Study of genes involved in chronic myeloid leukemia with t (3; 21) (q26; q22) in blastic crisis]. Liu XP; Zhang MR; Dai Y; Zhang L; Li R; Hao YS; Xiao ZJ Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):310-3. PubMed ID: 16875579 [TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of the short arm of chromosome 12 during clonal evolution in myelodysplastic syndrome with t(5;12)(q13;p13) involving the ETV6 gene. Yamamoto K; Nagata K; Yagasaki F; Tsurukubo Y; Tamura A; Taniwaki M; Hamaguchi H Cancer Genet Cytogenet; 2000 Jun; 119(2):113-7. PubMed ID: 10867145 [TBL] [Abstract][Full Text] [Related]
8. 3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review. De Braekeleer M; Le Bris MJ; De Braekeleer E; Basinko A; Morel F; Douet-Guilbert N Future Oncol; 2015; 11(11):1675-86. PubMed ID: 26043219 [TBL] [Abstract][Full Text] [Related]
9. A case of atypical myelodysplastic syndrome with micromegakaryocytes, normal platelet count, and t(3;12)(q21;p13) with inv(3)(q21q26). Schnittger S; Schoch C; Streubel B; Hinrichs HF; Otremba B; Parwaresch R; Fonatsch C Genes Chromosomes Cancer; 1997 Nov; 20(3):292-8. PubMed ID: 9365837 [TBL] [Abstract][Full Text] [Related]
10. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804 [TBL] [Abstract][Full Text] [Related]
11. Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1. van de Loosdrecht AA; Kok K; de Vries B; van der Veen AY; van den Berg E; Esselink MT; Marynen P; Vellenga E; van Imhoff GW Leukemia; 2000 Oct; 14(10):1857-8. PubMed ID: 11021761 [No Abstract] [Full Text] [Related]
12. Characterization of a t(10;12)(q24;p13) in a case of CML in transformation. Aguiar RC; Chase A; Oscier DG; Carapeti M; Goldman JM; Cross NC Genes Chromosomes Cancer; 1997 Dec; 20(4):408-11. PubMed ID: 9408758 [TBL] [Abstract][Full Text] [Related]
13. Myeloid neoplasms associated with t(3;12)(q26.2;p13) are clinically aggressive, show myelodysplasia, and frequently harbor chromosome 7 abnormalities. Ronaghy A; Hu S; Tang Z; Wang W; Tang G; Loghavi S; Li S; Thakral B; Medeiros LJ; Muzzafar T Mod Pathol; 2021 Feb; 34(2):300-313. PubMed ID: 33110238 [TBL] [Abstract][Full Text] [Related]
14. Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute myelogenous leukemia with t(5;12)(q31;p13). Yagasaki F; Jinnai I; Yoshida S; Yokoyama Y; Matsuda A; Kusumoto S; Kobayashi H; Terasaki H; Ohyashiki K; Asou N; Murohashi I; Bessho M; Hirashima K Genes Chromosomes Cancer; 1999 Nov; 26(3):192-202. PubMed ID: 10502316 [TBL] [Abstract][Full Text] [Related]
15. Myeloid neoplasm with t(3;8)(q26;q24): report of six cases and review of the literature. Xu X; Su M; Levy NB; Mohtashamian A; Monaghan S; Kaur P; Zaremba C; Garcia R; Broome HE; Dell'Aquila ML; Wang HY Leuk Lymphoma; 2014 Nov; 55(11):2532-7. PubMed ID: 24397594 [TBL] [Abstract][Full Text] [Related]
16. Expression of the ETS2 and transferrin receptor genes in Philadelphia-positive chronic myeloid leukemia patients with a reciprocal t(3;21). Lafage-Pochitaloff M; Courcoul M; Simonetti J; Sainty D; Dastugue N; Tabilio A; Hagemeijer A; Birg F Genes Chromosomes Cancer; 1992 Jul; 5(1):1-13. PubMed ID: 1384656 [TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. Wlodarska I; La Starza R; Baens M; Dierlamm J; Uyttebroeck A; Selleslag D; Francine A; Mecucci C; Hagemeijer A; Van den Berghe H; Marynen P Blood; 1998 Feb; 91(4):1399-406. PubMed ID: 9454771 [TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24). Lin P; Lennon PA; Yin CC; Abruzzo LV Cancer Genet Cytogenet; 2009 Sep; 193(2):119-22. PubMed ID: 19665075 [TBL] [Abstract][Full Text] [Related]
19. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia. Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006 [TBL] [Abstract][Full Text] [Related]
20. CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737. Shimada K; Tomita A; Minami Y; Abe A; Hind CK; Kiyoi H; Cragg MS; Naoe T Exp Hematol; 2012 Sep; 40(9):724-737.e2. PubMed ID: 22634393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]